Krystal Biotech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KRYS and other ETFs, options, and stocks.

About KRYS

Krystal Biotech, Inc. operates as a biotechnology company, which engages in discovery, development, manufacturing, and commercialization of pharmaceutical products. It offers the product, VYJUVEK. 

CEO
Krish S. Krishnan
CEOKrish S. Krishnan
Employees
295
Employees295
Headquarters
Pittsburgh, Pennsylvania
HeadquartersPittsburgh, Pennsylvania
Founded
2016
Founded2016
Employees
295
Employees295

KRYS Key Statistics

Market cap
8.37B
Market cap8.37B
Price-Earnings ratio
38.04
Price-Earnings ratio38.04
Dividend yield
Dividend yield
Average volume
290.06K
Average volume290.06K
High today
$303.00
High today$303.00
Low today
$283.50
Low today$283.50
Open price
$291.12
Open price$291.12
Volume
414.55K
Volume414.55K
52 Week high
$303.00
52 Week high$303.00
52 Week low
$122.80
52 Week low$122.80

Stock Snapshot

The current Krystal Biotech(KRYS) stock price is $284.57, with a market capitalization of 8.37B. The stock trades at a price-to-earnings (P/E) ratio of 38.04.

As of 2026-05-06, Krystal Biotech(KRYS) stock has fluctuated between $283.50 and $303.00. The current price stands at $284.57, placing the stock +0.4% above today's low and -6.1% off the high.

Krystal Biotech(KRYS) shares are trading with a volume of 414.55K, against a daily average of 290.06K.

During the past year, Krystal Biotech(KRYS) stock moved between $122.80 at its lowest and $303.00 at its peak.

During the past year, Krystal Biotech(KRYS) stock moved between $122.80 at its lowest and $303.00 at its peak.

KRYS News

TipRanks 1d
Krystal Biotech Earnings Call Highlights Profitable Growth

Krystal Biotech, Inc. ((KRYS)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data a...

The Motley Fool 2d
Krystal Q1 2025 Earnings Transcript

Image source: The Motley Fool. Tuesday, May 6, 2025 at 8:30 a.m. ET Call participants Chief Executive Officer — Krish S. Krishnan President & Chief Operating O...

Krystal Q1 2025 Earnings Transcript
Nasdaq 2d
Krystal Biotech, Inc. Bottom Line Climbs In Q1

(RTTNews) - Krystal Biotech, Inc. (KRYS) reported a profit for its first quarter that Increased, from the same period last year The company's earnings totaled...

Krystal Biotech, Inc. Bottom Line Climbs In Q1

Analyst ratings

92%

of 12 ratings
Buy
91.7%
Hold
8.3%
Sell
0%

More KRYS News

TipRanks 2d
Krystal Biotech reports Q1 EPS $1.83, consensus $1.42

Reports Q1 revenue $116.36M, consensus $112.13M. “Following a successful 2025, we are entering 2026 with strong momentum, including two potential registrational...

Simply Wall St 3d
Krystal Biotech Valuation Check After Strong One Year Shareholder Returns

Advertisement Krystal Biotech: recent performance snapshot Krystal Biotech (KRYS) has drawn attention after a period of mixed share price moves, with a 1.4% g...

Krystal Biotech Valuation Check After Strong One Year Shareholder Returns

People also own

Based on the portfolios of people who own KRYS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.